Clinic
Christopher Greater Area Rural Health Planning Corporation
Christopher Greater Area Rural Health Planning Corporation was paid $4.25M by Medicaid between Jan 2018 and Dec 2024, across 30 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 100% of everything it billed.
33Billing provider infoCHRISTOPHER GREATER AREA RURAL HEALTH PLANNING CORPORATION
ELDORADO, IL 62930
ELDORADO, IL 62930
33aNPI1144200825assigned 01/19/2006
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$4.25M
24GClaims86,784
24DCodes billed30
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in Illinois
Rank by total paid#102 of 296
Median peer was paid$1.43M
This provider vs. median3.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,189 | $284K | |
| 2019 | 19,623 | $668K | |
| 2020 | 16,062 | $706K | |
| 2021 | 8,635 | $425K | |
| 2022 | 8,114 | $452K | |
| 2023 | 13,027 | $827K | |
| 2024incomplete | 14,134 | $891K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 100% | 42,691 | 30,581 | $4.25M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,200 | 842 | $1K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 0% | 1,096 | 969 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 1,082 | 855 | $0.00 |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 0% | 24,667 | 18,194 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 613 | 437 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 109 | 73 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 1,730 | 1,458 | $0.00 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 265 | 226 | $0.00 |
| 87428 | 0% | 566 | 507 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 1,276 | 1,003 | $0.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 293 | 262 | $0.00 |
18 more codes
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 0% | 90 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 483 | $0.00 |
| 90686 | 0% | 229 | $0.00 | |
| 3074F | 0% | 881 | $0.00 | |
| 80349 | 0% | 35 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 238 | $0.00 |
| 3080F | 0% | 266 | $0.00 | |
| 80061 | Lipid panel | 0% | 677 | $0.00 |
| 3078F | 0% | 877 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 1,894 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 4,359 | $0.00 |
| 99201 | 0% | 660 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 156 | $0.00 |
| 3077F | 0% | 269 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 36 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 20 | $0.00 |
| 81025 | 0% | 12 | $0.00 | |
| 81003 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMITROKA, KIM (PRESIDENT CEO)
| Provider | Location | Paid |
|---|---|---|
| Christopher Greater Area Rural Health Planning Corporation | Christopher, IL | $16.82M |
| Christopher Greater Area Rural Health Planning Corporation | Mt Vernon, IL | $9.52M |
| Christopher Greater Area Rural Health Planning Corporation | Johnston City, IL | $4.42M |
| Christopher Greater Area Rural Health Planning Corporation | Du Quoin, IL | $3.80M |
| Christopher Greater Area Rural Health Planning Corp | Flora, IL | $1.94M |
| Christopher Greater Area Rural Health Planning Corporation | Christopher, IL | $1.80M |
| Christopher Greater Area Rural Health Planning Corporation | Sesser, IL | $544K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.